Frataxin, iron-sulfur clusters, heme, ROS, and aging

Antioxidants and Redox Signaling

Volumn 8, Issue 3-4, 2006, Pages 506-516

  Napoli, Eleonora ^a   Taroni, Franco ^b   Cortopassi, Gino A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; CITRATE SYNTHASE; CYTOCHROME C; CYTOCHROME C OXIDASE; ENZYME INHIBITOR; FRATAXIN; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; HEME; HYDROGEN PEROXIDE; IRON SULFUR PROTEIN; MITOCHONDRIAL ENZYME; PROTEIN ISCU2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE; SUPEROXIDE; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

AGING; ARTICLE; CELL MUTANT; CONTROLLED STUDY; CYTOCHROME C OXIDASE DEFICIENCY; ELECTRON TRANSPORT; ENZYME ACTIVATION; ENZYME ACTIVITY; FRIEDREICH ATAXIA; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYMPHOBLAST; MITOCHONDRION; PRIORITY JOURNAL;

AGING; CYTOCHROMES C; GLUTATHIONE; HEME; HUMANS; IRON-BINDING PROTEINS; IRON-SULFUR PROTEINS; LYMPHOCYTES; MITOCHONDRIA; MODELS, BIOLOGICAL; MUTATION; OXYGEN; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

ATAXIA;

EID: 33646696625     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2006.8.506     Document Type: Article

References (66)

1. Ames BN, Shigenaga MK, and Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90: 7915-7922, 1993.
2. Atamna H, Liu J, and Ames BN. Heme deficiency selectively interrupts assembly of mitochondrial complex IV in human fibroblasts: revelance to aging. J Biol Chem 276: 48410-48416, 2001.
3. Atamna H, Killilea DW, Killilea AN, and Ames BN. Heme deficiency may be a factor in the mitochondrial and neuronal decay of aging. Proc Natl Acad Sci USA 99: 14807-14812, 2002.
4. Bidichandani SI, Purandare SM, Taylor EE, Gumin G, Machkhas H, Harati Y, Gibbs RA, Ashizawa T, and Patel PI. Somatic sequence variation at the Friedreich ataxia locus includes complete contraction of the expanded GAA triplet repeat, significant length variation in serially passaged lymphoblasts and enhanced mutagenesis in the flanking sequence. Hum Mol Genet 8: 2425-2436, 1999.
5. Birch-Machin MA and Turnbull DM. Assaying mitochondrial respiratory complex activity in mitochondria isolated from human cells and tissues. Methods Cell Biol 65: 97-117, 2001
6. Branda SS, Yang ZY, Chew A, and Isaya G. Mitochondrial intermediate peptidase and the yeast frataxin homolog together maintain mitochondrial iron homeostasis in Saccharomyces cerevisiae. Hum Mol Genet 8: 1099-1110, 1999.
7. Campian JL, Qian M. Gao X, and Eaton JW. Oxygen tolerance and coupling of mitochondrial electron transport. J Biol Chem 279: 46580-46587, 2004.
8. Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, Trottier Y, Kish SJ, Faucheux B, Trouillas P, Authier FJ, Durr A, Mandel JL, Vescovi A, Pandolfo M, and Koenig M. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet 6: 1771-1780, 1997.
9. Cavadini P, Gellera C, Patel PI, and Isaya G. Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae. Hum Mol Genet 9: 2523-2530, 2000.
10. Chantrel-Groussard K, Geromel V, Puccio H, Koenig M, Munnich A, Rotig A, and Rustin P. Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. Hum Mol Genet 10: 2061-2067, 2001.
11. Cino M and Del Maestro RF. Generation of hydrogen peroxide by brain mitochondria: the effect of reoxygenation following postdecapitative ischemia. Arch Biochem Biophys 269: 623-638, 1989.
12. Cortopassi GA and Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res 18: 6927-6933, 1990.
13. Cortopassi GA and Wong A. Mitochondria in organismal aging and degeneration Biochim Biophys Acta 1410: 183-193, 1999.
14. - eneration in the complex III of the electron transport chain. Mol Cell Biochem 184: 21-33, 1998.
15. Duby G, Foury F, Ramazzotti A, Herrmann J, and Lutz T. A non-essential function for yeast frataxin in iron-sulfur cluster assembly. Hum Mol Genet 11: 2635-2643, 2002.
16. Edwards MG, Sarkar D, Klopp R, Morrow JD, Weindruch R, and Prolla TA. Age-related impairment of the transcriptional responses to oxidative stress in the mouse heart. Physiol Genomics 13: 119-127, 2003.
17. Foury F and Cazzalini O. Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria. FEBS Lett 411: 373-377, 1997.
18. Foury F. Low iron concentration and aconitase deficiency in a yeast frataxin homologue deficient strain. FEBS Lett 456: 281-284, 1999.
19. 2 formation by rat heart mitochondria on substrate availability and donor age. J Bioenerg Biomembr 29: 89-95, 1997.
20. Harman D. The biologic clock: the mitochondria? J Am Geriatr Soc 20: 145-147, 1972.
21. He Y, Aalam SL, Proteasa SV, Zhang Y, Lesuisse E, Dancis A, and Stemmler TL. Yeast frataxin solution structure, iron binding, and ferrochelatase interaction. Biochemistry 43: 16254-16262, 2004.
22. Huynen MA, Snel B, Bork P, and Gibson TJ. The phylogenetic distribution of frataxin indicates a role in iron-sulfur cluster protein assembly. Hum Mol Genet 10: 2463-2468, 2001.
23. Jauslin ML, Meier T, Smith RA, and Murphy MP. Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J 17: 1972-1974, 2003.
24. Johnson WT and Thomas AC. Copper deprivation potentiates oxidative stress in HL-60 cell mitochondria. Proc Soc Exp Biol Med 222: 147-152, 1999.
25. Judge S, Jang YM, Smith A, Hagen T, and Leeuwenburgh C. Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J 19: 419-421, 2005.
26. Koenig M. Friedreich ataxia and AVED. In: The Metabolic and Molecular Basis of Inherited Disease (Scriver C, Beaudet A, Sly W, and Valle D, eds). New York, McGraw Hill, 2001; pp. 5845-5855.
27. Korshunov SS, Skulachev VP, and Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416: 15-18, 1997.
28. Lange H, Muhlenhoff U, Denzel M, Kispal G, and Lill R. The heme synthesis defect of mutants impaired in mitochondrial iron-sulfur protein biogenesis is caused by reversible inhibition of ferrochelatase. J Biol Chem 279: 29101-29108, 2004.
29. Lee CK, Klopp RG, Weindruch R, and Prolla TA. Gene expression profile of aging and its retardation by caloric restriction. Science 285: 1390-1393, 1999.
30. Lesuisse E, Santos R, Matzanke BF, Knight SA, Camadro JM, and Dancis A. Iron use for haeme synthesis is under control of the yeast frataxin homologue (Yfh1). Hum Mol Genet 15: 879-889, 2003.
31. Mariotti C and Di Donato S. Cerebellar/spinocerebellar syndromes Neurol Sci 22: S88-S92, 2001.
32. Melov S, Ravenscroft J, Malik S, Gill MS, Walker DW, Clayton PE, Wallace DC, Malfroy B, Doctrow SR, and Lithgow GJ. Extension of life-span with superoxide dismutase/catalase mimetics. Science 289: 1567-1569, 2000.
33. Miro O, Cardellach F, Barrientos A, Casademont J, Rotig A, and Rustin P. Cytochrome c oxidase assay in minute amounts of human skeletal muscle using single wavelength spectrophotometers. J Neurosci Methods 80:107-111, 1998.
34. Muhlenhoff U, Richhardt N, Ristow M, Kispal G, and Lill R. The yeast frataxin homolog Yfh1p plays a specific role in the maturation of cellular Fe/S proteins. Hum Mol Genet 11: 2025-2036, 2002.
35. O'Neill HA, Gakh O, and Isaya G. Supramolecular assemblies of human frataxin are formed via subunit-subunit interactions mediated by a non-conserved amino-terminal region. J Mol Biol 345: 433-439, 2005.
36. Pandolfo M. Molecular pathogenesis of Friedreich ataxia. Arch Neurol 56: 1201-1208, 1999.
37. Pandolfo M. Iron metabolism and mitochondrial abnormalities in Friedreieh ataxia. Blood Cells Mol Dis 29: 536-547, 2002.
38. Park S, Gakh O, O'Neill HA, Mangravita A, Nichol H, Ferreira GC, and Isaya G. Yeast frataxin sequentially chaperones and stores iron by coupling protein assembly with iron oxidation. J Biol Chem 278: 31340-31351, 2003.
39. Patel PI and Isaya G. Friedreich ataxia: from GAA triplet-repeat expansion to frataxin deficiency. Am J Hum Genet 69: 15-24, 2001.
40. Peled-Kamar M, Lotem J, Wirguin I, Weiner L, Hermalin A, and Groner Y. Oxidative stress mediates impairment of muscle function in transgenic mice with elevated level of wild-type Cu/Zn superoxide dismutase. Proc Natl Acad Sci USA 94: 3883-3887, 1997.
41. Pereverzev MO, Vygodina TV, Konstantinov AA, and Skulachev VP. Cytochrome c, an ideal antioxidant. Biochem Soc Trans 31: 1312-1315, 2003.
42. Prohaska JR and Ganther HE. Glutathione peroxidase activity of glutathione-5-transferases purified from rat liver. Biochem Biophys Res Commun 76: 437-445, 1976.
43. Puccio H, Simon D, Cossee M, Criqui-Filipe P, Tiziano F, Melki J, Hindelang C, Matyas R, Rustin P, and Keonig M. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 27: 181-186, 2001.
44. Ramazzotti A, Vanmansart V, and Foury F. Mitochondrial functional interactions between frataxin and Isu1p, the iron-sulfur cluster scaffold protein, in Saccharomyces cerevisiae. FEBS Lett 557: 215-220, 2004.
45. Rotig A, De Lonlay P, Chretien D, Foury F, Koenig M, Sidi D, Munnich A, and Rustin P. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 17: 215-217, 1997.
46. Rotig A, Sidi D, Munnich A, and Rustin P. Molecular insights into Friedreich's ataxia and antioxidant-based therapies. Trends Mol Med 8: 221-224, 2002.
47. Rustin P. The use of antioxidants in Friedreich's ataxia treatment. Expert Opin Investig Drugs 12: 569-575, 2003.
48. Schulz H, Pellicioli EC, and Thony-Meyer L. New insights into the role of CcmC, CcmD and CcmE in the haem delivery pathway during cytochrome c maturation by a complete mutational analysis of the conserved tryptophan-rich motif of CcmC. Mol Microbiol 37: 1379-1388, 2000.
49. Scotto AW, Rinehart RW, and Beattie DS. Aging-related decreases in hepatic mitochondrial and cytosolic delta-aminolevulinic acid synthase during experimental porphyria. Arch Biochem Biophys 222: 150-157, 1983.
50. Seznech H, Simon D, Monassier L, Criqui-Filipe P, Gansmuller A, Rustin P, Koenig M, and Puccio H. Idebenone delays the onset of cardiac functional alteration without correction of Fe-S enzymes deficit in a mouse model for Friedreich ataxia. Hum Mol Genet 13: 1017-1024, 2004.
51. Seznec H, Simon D, Bouton C, Reutenauer L, Hertzog A, Golik P, Procaccio V, Patel M, Drapier JC, Koenig M, and Puccio H. Friedreich ataxia: the oxidative stress paradox. Hum Mol Genet 14: 463-474, 2005.
52. Sohal RS. Role of oxidative stress and protein oxidation in the aging process. Free Radic Biol Med 33: 37-44, 2002.
53. Srere PA. Citrate synthase. In: Methods in Enzymology: Oxidation and Phosphorylation. (Lowenstein J, ed) New York, NY: Academic Press; 1969; pp. 3-11.
54. Stehling O, Elsasser HP, Bruckel B, Muhlenhoff U, and Lill R. Iron-sulfur protein maturation in human cells: evidence for a function of frataxin. Hum Mol Genet 13: 3007-3015, 2004.
55. Sturtz LA, Diekert K, Jensen LT, Lill R, and Culotta VC. A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage. J Biol Chem 276: 38084-38089, 2001.
56. Tan G, Chen LS, Lonnerdal B, Gellera C, Taroni FA, and Cortopassi GA. Frataxin expression rescues mitochondrial dysfunctions in FRDA cells. Hum Mol Genet 10: 2099-2107, 2001.
57. Tan G, Napoli E, Taroni F, and Cortopassi G. Decreased expression of genes involved in sulfur amino acid metabolism in frataxin-deficient cells. Hum Mol Genet 12: 1699-1711, 2003.
58. Trounce IA, Kim YL, Jun AS, and Wallace DC. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264: 484-509, 1996.
59. Turrens JF, Alexandre A, and Lehninger AL. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch Biochem Biophys 237: 408-414, 1985.
60. Turrens JF. Mitochondrial formation of reactive oxygen species. J Physiol 552: 335-344, 2003.
61. Urbina HD, Silberg JJ, Hoff KG, and Vickery LE. Transfer of sulfur from IscS to IscU during Fe/S cluster assembly. J Biol Chem 276: 44521-44526, 2001.
62. Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F, and Cortopassi G. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet 8: 425-430, 1999.
63. Yoon T and Cowan JA. Iron-sulfur cluster biosynthesis. Characterization of frataxin as an iron donor for assembly of [2Fe-2S] clusters in ISU-type proteins. J Am Chem Soc 125: 6078-6084, 2003.
64. Yuyama K, Yamamoto H, Nishizaki I, Kato T, Sora I, and Yamamoto T. Caspase-independent cell death by low concentrations of nitric oxide in PC12 cells: Involvement of cytochrome C oxidase inhibition and the production of reactive oxygen species in mitochondria. J Neurosci Res 73: 351-363, 2003.
65. Zhang J, Graham DG, Montine TJ, and Ho YS. Enhanced N-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. J Neuropathol Exp Neurol 59: 53-61, 2000.
66. Schoenfeld RA, Napoli E, Wong A, Zhan S, Reutenauer L, Morer D, Buckpitt AR, Taroni F, Lonnerdal B, Ristow M, Puccio H, Cortopassi GA. Frataxin deficiency alters heme pathway transcripts and decreases heme metabolites in mammalian cells. Hum Mol Genet 14: 3787-3799, 2006.